FILE PHOTO: The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, April 25, 2017. REUTERS/Hannah McKay/File Photo
(Reuters) - The European Union's healthcare regulator said on Wednesday there currently is no evidence which links anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19, the disease caused by the novel coronavirus.
The European Medicines Agency (EMA) said it was monitoring the situation, adding that patients and healthcare professionals should consider all treatment options including paracetamol and anti-inflammatory drugs to treat fever or pain in patients with COVID-19. (https://bit.ly/2U0zLwC)
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
